'Too costly' drug can slow dementia 'by up to eight years'

AN Alzheimer's drug deemed too costly for the NHS can slow progression of dementia by up to eight years, researchers claim.

- BY HANNA GEISSLER Health Editor

UK medicines assessors ruled earlier this year that the benefits of two breakthrough therapies were too modest to justify the price, after trials showed they could delay progression from mild to moderate disease by four to six months.